Comparison of the Treatments of Obinutuzumab + Venetoclax Versus Obinutuzumab + Chlorambucil in Patients With Chronic Lymphocytic Leukemia
Clinical trial NCT02242942 · COMPLETED
Trial details
- NCT number
- NCT02242942
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-12-31
- Primary completion
- 2018-08-17
- Enrollment
- 445
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.